| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 06/16/2009 | CA2447640C Substituted anilide derivative, intermediate thereof, agricultural and horticultural chemical and its usage |
| 06/11/2009 | WO2009071726A1 Method for the preparation of capecitabine and intermediates used in said method |
| 06/11/2009 | WO2009071535A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2009 | WO2009071449A1 Pyridylmethyl-sulfonamide compounds |
| 06/11/2009 | WO2009071448A1 Pyridylmethyl-sulfonamide compounds |
| 06/11/2009 | WO2008093325A3 Polymorphs of 3-(e)-2-{2-[6-(2-cyanophenoxy) pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate |
| 06/11/2009 | US20090149487 4,5-diphenyl-pyrimidinylamino substituted carboxylic acids, method for the production and use thereof as medicaments |
| 06/11/2009 | US20090149486 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments |
| 06/11/2009 | US20090149485 Pyrimidinediones as tyrosine kinase inhibitors |
| 06/11/2009 | US20090149484 Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/11/2009 | US20090149477 use for lowering blood glucose, treating diabetes, or increasing insulin release; 7-(4,5-Diphenylpyrimidin-2-yl)-6-heptynoic Acid |
| 06/11/2009 | US20090149476 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy |
| 06/11/2009 | US20090149469 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors |
| 06/11/2009 | US20090149468 Substituted heterocyclic compounds and methods of use |
| 06/11/2009 | US20090149456 2-Pyrimidinyl Pyrazolopyridine ErbB Kinase Inhibitors |
| 06/11/2009 | US20090148531 Rate-controlled particles |
| 06/11/2009 | CA2707653A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2009 | CA2705489A1 Pyridylmethyl-sulfonamide compounds |
| 06/10/2009 | EP2066645A2 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions |
| 06/10/2009 | EP2066644A2 Salts of rosuvastatin and processes for their preparation |
| 06/10/2009 | EP2066632A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
| 06/10/2009 | EP1597251B1 Pyrimidine compounds |
| 06/10/2009 | CN101454294A Quinazolines for pdk1 inhibition |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497326C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 06/10/2009 | CN100497318C Method for preparing 2,4,6-trichloro pyrimidine |
| 06/09/2009 | US7544799 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 06/09/2009 | US7544691 Guanidine derivatives |
| 06/09/2009 | US7544690 MCH receptor antagonists |
| 06/09/2009 | US7544688 Hetereoaryl nitrile derivatives |
| 06/09/2009 | US7544675 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 06/09/2009 | CA2583764C Thrombopoietin activity modulating compounds and methods |
| 06/09/2009 | CA2403721C Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/04/2009 | WO2009069291A1 Prophylactic and/or therapeutic composition for disease caused by inhalation of tobacco smoke |
| 06/04/2009 | WO2009068512A1 2 -amino-pyrimidine derivatives as histamine h4 antagonists |
| 06/04/2009 | WO2009007300A3 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
| 06/04/2009 | WO2008155669A3 Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 06/04/2009 | US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof |
| 06/04/2009 | US20090143414 Quinazoline Derivatives Having Tyrosine Kinase Inhibitory Activity |
| 06/04/2009 | US20090143389 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2009 | US20090143384 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer |
| 06/04/2009 | US20090143376 Fused Heterocyclic Compounds and Their Use as Sirtuin Modulators |
| 06/04/2009 | US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 06/03/2009 | EP2064191A1 Aspartyl protease inhibitors |
| 06/03/2009 | EP2064190A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods |
| 06/03/2009 | EP2064177A2 Protease inhibitors |
| 06/03/2009 | CN101448794A Pyrimidine derivatives for the treatment of amyloid-related diseases |
| 06/03/2009 | CN101445487A Preparation method of 3H-quinazoline-4-ketones compounds |
| 06/03/2009 | CN101445486A Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone |
| 06/03/2009 | CN101445485A Synthesis method of 4,6-dichloro-5-fluoropyrimidine compound |
| 06/03/2009 | CN100494183C Preparation process of key intermediate 2-cyano pyrimidine of bosentan |
| 06/03/2009 | CN100494177C Bi-amido heterocyclic derivative with antitumour activity and its preparation method and use |
| 06/02/2009 | US7541465 Substituted 2-aminoacetamides and the use thereof |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541361 N-[4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 06/02/2009 | US7541360 2-amino-4-N-cyclohexylmethylamino-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-pteridine; treatment of pathological blood pressure decreases, such as occur in septic or hemorrhagic shock, in tumor or cancer therapy with cytokines, liver cirrhosis; ulcerative colitis; NO synthase inhibitor |
| 06/02/2009 | CA2503900C Purine compounds and use thereof as cannabinoid receptor ligands |
| 06/02/2009 | CA2452253C Novel crystal of arylethenesulfonamide derivative and preparation process thereof |
| 06/02/2009 | CA2362594C Process for the production of tert-butyl (e)-(6-[2- [4-(4-fluorophenyl) -6-isopropyl-2-[ methyl (methylsulfonyl) amino] pyrimidin-5-yl] vinyl](4r, 6s)-2,2-dimethyl [1,3]dioxan-4-yl) acetate |
| 06/02/2009 | CA2116421C Inhibitors of hydroxyphenylpyruvate dioxygenase and an assay for identification of inhibitors |
| 05/28/2009 | WO2009067621A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | WO2009067600A2 Biaryl pde4 inhibitors for treating inflammation |
| 05/28/2009 | WO2009067081A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/28/2009 | WO2009066084A1 2 -morpholinopyrimidines and their use as pi3 kinase inhibitors |
| 05/28/2009 | WO2009048752A3 Insecticidal substituted azinyl derivatives |
| 05/28/2009 | WO2009030467A3 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
| 05/28/2009 | WO2007050381A3 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 05/28/2009 | US20090137804 Compounds and Compositions as Protein Kinase Inhibitors |
| 05/28/2009 | US20090137803 5-protected aminopyrimidine compound, production method thereof and intermediate therefor |
| 05/28/2009 | US20090137802 A2b adenosine receptor antagonists |
| 05/28/2009 | US20090137611 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives |
| 05/28/2009 | US20090137589 Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds And Their Uses |
| 05/28/2009 | US20090137588 Heteroaryl compounds and uses thereof |
| 05/28/2009 | US20090137585 N-acylsulfonamide apoptosis promoters |
| 05/28/2009 | US20090137583 2-aminoquinazoline derivatives |
| 05/28/2009 | US20090137575 Fused Tetracyclic mGluR1 Antagonists as Therapeutic Agents |
| 05/28/2009 | US20090137567 Methods for Treating Blood Disorders |
| 05/28/2009 | US20090137557 Calcilytic Compounds |
| 05/28/2009 | US20090137021 Anti-inflammatory medicaments |
| 05/28/2009 | US20090136473 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | US20090133318 Anthranilamide insecticides |
| 05/28/2009 | CA2722611A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | CA2722582A1 Biaryl pde4 inhibitors for treating inflammation |
| 05/28/2009 | CA2704214A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/27/2009 | EP2061773A2 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 05/27/2009 | EP2061771A1 Aspartyl protease inhibitors containing a tricyclic ring system |
| 05/27/2009 | EP2061770A1 Piperazine compounds with herbicidal action |
| 05/27/2009 | EP2061764A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr) |
| 05/27/2009 | EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders |
| 05/27/2009 | EP2061469A2 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 05/27/2009 | EP1663241B1 5-arylpyrimidines as anticancer agents |
| 05/27/2009 | EP0934287B1 Heterocyclic esters and amides |
| 05/27/2009 | CN101443664A Mass tags for quantitative analyses |
| 05/27/2009 | CN101443318A Heterobicyclic carboxamides as inhibitors for kinases |
| 05/27/2009 | CN101440066A Benzodiazepinic amine nitrite compound, preparation and use thereof |
| 05/27/2009 | CN100491371C Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 05/27/2009 | CN100491358C Pyrimidinone compounds, compositions and methods |
| 05/27/2009 | CN100491356C Compounds exhibiting thrombopoietin receptor agaonism |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |